Abstract
Human medicines European public assessment report (EPAR): Deferasirox Mylan, deferasirox, Iron Overload,beta-Thalassemia, Date of authorisation: 26/09/2019, Status: Authorised
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have